TRIPS
:
WHO/WTO WORKSHOP ON DRUG PRICING AND FINANCING, HØSBJØR
2001
Participants
As on 6 April 2001. The workshop was 8–11 April 2001
Applebaum, Harvey
Covington & Burling
Balasubramaniam, K Consumers International
Bale, Harvey IFPMA — International Federation of Pharmaceutical Manufacturers Associations
Bayer, Ron Columbia University
Berkley, Seth IAVI – International AIDS Vaccine Initiative
Bisonga, John Customs and Excise Department, Kenya
Bloomer, Phil Oxfam
Chidyausiku, Boniface Zimbabwe
Cleves, Julia UNAIDS
Correa, Carlos University of Buenos Aires
Danzon, Patricia Wharton School, University of Pennsylvania (Videoconference)
Faber, Gunter GlaxoSmithKline
Fleet, Julian UNAIDS
Fransen, Lieve European Commission
Haddad, Bill CIPLA; U.S. Research and Development Corporation
Hardwick, Chuck Pfizer, Inc.
Harper, Malaya UK DFID
Harrington, Mark Treatment Coalition
Heimler, Alberto Autorita Garante della Concorrenza e del Mercato
Henry, David Newcastle University, Australia
Hessou, Pascal ACAME
Hoekman, Bernard World Bank
Itschner, Albert Novartis
Johns, Desmond South African Government
Jorge, Fabiana Latin American Generic Association
Kadama, Patrick Ministry of Health, Uganda
Laing, Richard Boston University
Love, Jamie Consumer Project on Technology
McCullough, Keith Vuna Healthcare Logistics
Martin, Jacques-François Global Fund for Children's Vaccines
Medlin, Carol Institute for Global Health
Miles, Cecile Ranbaxy
Nightingale, Stuart US DHHS
Ochola, Dorothy Uganda Improved Access to HIV/AIDS Drugs
Papovich, Joe US Trade Representative
Pedersen, Hanne UNICEF
Piot, Peter UNAIDS
Redwood, Heinz Author and Industry Consultant
Rovira, Joan World Bank
Sachs, Jeffrey Harvard University (Videoconference)
Saunders, Christian UNFPA
Scherer, Mike Harvard University
Schoonveld, Ed Cambridge Pharma Consultancy
So, Anthony Rockefeller Foundation
Speaker, Mark Bristol-Myers Squibb Co.
Steiger, William US DHHS
Stenvik, Are Oslo University
Sturchio, Jeffrey Merck & Co., Inc.
Teixeira, Paulo Ministry of Health, Brazil
’t Hoen, Ellen Médecins Sans Frontières
Torongo, Mabel International Pharmaceutical Federation
Vandoren, Paul European Commission
Varet, Françoise Ministry of Health, France
Wanyanga, Wilberforce COSMOS
Wecker, John Boehringer Ingelheim
Wibulpolprasert, Suwit Ministry of Health, Thailand
Wilder, Richard Powell, Goldstein, Frazer & Murphy
Wong, Clifford Kaiser Permanente (retired); MedImpact Healthcare Systems, Inc.
Woods, Guy Lacuna Research, Ltd.
Yamamoto, Junji Ministry of Health, Japan
WHO
Brundtland, Gro Harlem WHO
Creese, Andrew WHO
Dukes, Graham Consultant (International Journal of Risk and Safety in Medicine)
Lidén, Jon WHO
Neira, Maria WHO
Quick, Jonathan WHO
Suzuki, Yasuhiro WHO
Velasquez, German WHO
WTO
Anderson, Robert WTO Secretariat
Otten, Adrian WTO Secretariat
Tran Wasescha, Thu-Lang WTO Secretariat
Ungphakorn, Peter WTO Secretariat
Watal, Jayashree Consultant
Global Health Council
Daulaire, Nils Global Health Council
Hall, Sadhana Global Health Council
Sorensen, Karen Global Health Council
Norway
Christiansen, Ottar Norwegian Ministry of Foreign Affairs
Eckey, Susan Norwegian Ministry of Foreign Affairs
Haralstad, Hilde Norwegian Ministry of Foreign Affairs
Møgedal, Sigrun State Secretary for International Development, Norway
Riise, Anne Norwegian Ministry of Foreign Affairs
Sydnes, Anne Kristin Minister for International Development, Norway
Tonseth, Didrik Norwegian Ministry of Foreign Affairs
Walther, Arne Norwegian Ministry of Foreign Affairs
Participants of the Press conference following the Closing of the WHO/WTO - Hosbjor, Norway, 11 April 2001
Gro Harlem Brundtland the Director General of the World Health Organization;
Adrian Otten Director of the World Trade Organization’s Intellectual Property Division;
Sigrunn Møgedal State Secretary of the Ministry of Foreign Affairs of Norway
Nils Daulaire President of the Global Health Council.
Lieve Fransen Head of the Social Development Unit, Development Department of the European Commission;
Harvey Bale Director-General of the International Federation of Pharmaceutical Manufacturers’ Associations;
Ellen t’Hoen Coordinator for Médecins Sans Frontières’ Access to Essential Medicines Campaign.
Balasubramaniam, K Consumers International
Bale, Harvey IFPMA — International Federation of Pharmaceutical Manufacturers Associations
Bayer, Ron Columbia University
Berkley, Seth IAVI – International AIDS Vaccine Initiative
Bisonga, John Customs and Excise Department, Kenya
Bloomer, Phil Oxfam
Chidyausiku, Boniface Zimbabwe
Cleves, Julia UNAIDS
Correa, Carlos University of Buenos Aires
Danzon, Patricia Wharton School, University of Pennsylvania (Videoconference)
Faber, Gunter GlaxoSmithKline
Fleet, Julian UNAIDS
Fransen, Lieve European Commission
Haddad, Bill CIPLA; U.S. Research and Development Corporation
Hardwick, Chuck Pfizer, Inc.
Harper, Malaya UK DFID
Harrington, Mark Treatment Coalition
Heimler, Alberto Autorita Garante della Concorrenza e del Mercato
Henry, David Newcastle University, Australia
Hessou, Pascal ACAME
Hoekman, Bernard World Bank
Itschner, Albert Novartis
Johns, Desmond South African Government
Jorge, Fabiana Latin American Generic Association
Kadama, Patrick Ministry of Health, Uganda
Laing, Richard Boston University
Love, Jamie Consumer Project on Technology
McCullough, Keith Vuna Healthcare Logistics
Martin, Jacques-François Global Fund for Children's Vaccines
Medlin, Carol Institute for Global Health
Miles, Cecile Ranbaxy
Nightingale, Stuart US DHHS
Ochola, Dorothy Uganda Improved Access to HIV/AIDS Drugs
Papovich, Joe US Trade Representative
Pedersen, Hanne UNICEF
Piot, Peter UNAIDS
Redwood, Heinz Author and Industry Consultant
Rovira, Joan World Bank
Sachs, Jeffrey Harvard University (Videoconference)
Saunders, Christian UNFPA
Scherer, Mike Harvard University
Schoonveld, Ed Cambridge Pharma Consultancy
So, Anthony Rockefeller Foundation
Speaker, Mark Bristol-Myers Squibb Co.
Steiger, William US DHHS
Stenvik, Are Oslo University
Sturchio, Jeffrey Merck & Co., Inc.
Teixeira, Paulo Ministry of Health, Brazil
’t Hoen, Ellen Médecins Sans Frontières
Torongo, Mabel International Pharmaceutical Federation
Vandoren, Paul European Commission
Varet, Françoise Ministry of Health, France
Wanyanga, Wilberforce COSMOS
Wecker, John Boehringer Ingelheim
Wibulpolprasert, Suwit Ministry of Health, Thailand
Wilder, Richard Powell, Goldstein, Frazer & Murphy
Wong, Clifford Kaiser Permanente (retired); MedImpact Healthcare Systems, Inc.
Woods, Guy Lacuna Research, Ltd.
Yamamoto, Junji Ministry of Health, Japan
WHO
Brundtland, Gro Harlem WHO
Creese, Andrew WHO
Dukes, Graham Consultant (International Journal of Risk and Safety in Medicine)
Lidén, Jon WHO
Neira, Maria WHO
Quick, Jonathan WHO
Suzuki, Yasuhiro WHO
Velasquez, German WHO
WTO
Anderson, Robert WTO Secretariat
Otten, Adrian WTO Secretariat
Tran Wasescha, Thu-Lang WTO Secretariat
Ungphakorn, Peter WTO Secretariat
Watal, Jayashree Consultant
Global Health Council
Daulaire, Nils Global Health Council
Hall, Sadhana Global Health Council
Sorensen, Karen Global Health Council
Norway
Christiansen, Ottar Norwegian Ministry of Foreign Affairs
Eckey, Susan Norwegian Ministry of Foreign Affairs
Haralstad, Hilde Norwegian Ministry of Foreign Affairs
Møgedal, Sigrun State Secretary for International Development, Norway
Riise, Anne Norwegian Ministry of Foreign Affairs
Sydnes, Anne Kristin Minister for International Development, Norway
Tonseth, Didrik Norwegian Ministry of Foreign Affairs
Walther, Arne Norwegian Ministry of Foreign Affairs
Participants of the Press conference following the Closing of the WHO/WTO - Hosbjor, Norway, 11 April 2001
Gro Harlem Brundtland the Director General of the World Health Organization;
Adrian Otten Director of the World Trade Organization’s Intellectual Property Division;
Sigrunn Møgedal State Secretary of the Ministry of Foreign Affairs of Norway
Nils Daulaire President of the Global Health Council.
Lieve Fransen Head of the Social Development Unit, Development Department of the European Commission;
Harvey Bale Director-General of the International Federation of Pharmaceutical Manufacturers’ Associations;
Ellen t’Hoen Coordinator for Médecins Sans Frontières’ Access to Essential Medicines Campaign.